ARCH Venture Partners X Overage, L.P.'s Net Worth

$655 Million

Estimate Recalculated Feb 20, 2024 05:43PM EST

Who is ARCH Venture Partners X Overage, L.P.?

ARCH Venture Partners X Overage, L.P. has an estimated net worth of $655 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Neumora Therapeutics, Inc., Erasca, Inc., Verve Therapeutics, Inc., Sienna Biopharmaceuticals, Inc., and Prime Medicine, Inc..

SEC CIK

ARCH Venture Partners X Overage, L.P.'s CIK is 0001768905

Past Insider Trading and Trends

2021 was ARCH Venture Partners X Overage, L.P.'s most active year for acquiring shares with 8 total transactions. ARCH Venture Partners X Overage, L.P.'s most active month to acquire stocks was the month of January. 2021 was ARCH Venture Partners X Overage, L.P.'s most active year for disposing of shares, totalling 20 transactions. ARCH Venture Partners X Overage, L.P.'s most active month to dispose stocks was the month of January. 2023 saw ARCH Venture Partners X Overage, L.P. paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2022 ARCH Venture Partners X Overage, L.P. cashed out on 35,616,279 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Erasca, Inc. (ERAS) Snapshot price: $1.705

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
11.06M
11.06M
Jul 20
Form 3
0
0
No matching records found

Verve Therapeutics, Inc. (VERV) Snapshot price: $10.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.51M
2.51M
Jun 21
Form 3
0
0
No matching records found

Sienna Biopharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+59.61%
2.17M
$2.50
$5,414,500.00
5.8M
Feb 22
No matching records found

Prime Medicine, Inc. (PRME) Snapshot price: $6.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.2M
$6.25
$20,000,000.00
3.2M
Feb 15
Form 4
12.26M
$17.00
12.26M
Oct 24
Form 3
0
0
No matching records found

Sana Biotechnology, Inc. (SANA) Snapshot price: $6.155

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.39%
1.82M
$5.50
$9,999,995.50
35.56M
Feb 8
Form 4
+14,957.26%
43.75M
44.04M
Feb 8
Form 3
0
0
No matching records found